Several hedge funds recently changed their investments in Becton, Dickinson and Company (BDX). Jennison Associates increased their stake by 4.9% to 402,350 shares, now worth about $99.56 million. Norden Group boosted theirs significantly by 2,086.7%, owning 51,934 shares valued at $12.85 million. Franklin Street Advisors entered a new position worth $11.99 million. Avity Investment Management increased their stake by 3.5%, now holding 162,687 shares valued at $40.26 million. Caden Capital raised its stake by 26.7%, owning 83,417 shares worth $20.34 million. In total, 86.97% of BDX is owned by institutional investors.
Analyst Upgrades and Downgrades
Recently, analysts have adjusted their ratings on BDX. Evercore ISI raised their price target from $286 to $290 with an outperform rating. StockNews.com upgraded their rating from hold to buy. Stifel Nicolaus increased their target from $270 to $280 with a buy rating. Raymond James lowered their target from $275 to $270, maintaining an outperform rating. Citigroup upgraded their rating from neutral to buy and raised their target price from $255 to $275. Currently, BDX has a consensus Buy rating with an average target of $282.63, according to MarketBeat.
View Our Latest Report on Becton, Dickinson and Company
Becton, Dickinson and Company Price Performance
NYSE:BDX opened at $239.76. The company has various financial metrics: quick ratio 1.36, current ratio 1.85, debt-to-equity 0.70, market cap $69.29 billion, P/E ratio 52.81, P/E/G ratio 1.92, and beta 0.42. The stock’s 52-week low is $218.75 and high is $269.52. The fifty-day average is $236.55, while the 200-day is $235.57.
Becton, Dickinson reported earnings on August 1st, with EPS of $3.50, beating estimates of $3.31. Their revenue was $4.99 billion, slightly below the $5.08 billion estimate, but up 2.3% from last year. Analysts predict an EPS of 13.1 for this year.
Becton, Dickinson and Company Announces Dividend
The company declared a quarterly dividend of $0.95 per share, paid on September 30th, with an annual yield of 1.58%. Their payout ratio is currently 83.70%.
Becton, Dickinson and Company Profile
Becton, Dickinson develops and sells medical supplies, devices, and diagnostic products for healthcare providers and researchers globally, operating in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Read More
- Five stocks we like better than Becton, Dickinson and Company
- What is the Shanghai Stock Exchange Composite Index?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Nikes Post-Earnings Drop Presents a Buying Opportunity
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Microsofts Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Becton Dickinson and Company Daily – Enter your email below for a summary of the latest news and ratings on Becton Dickinson and related companies from MarketBeat.com’s FREE daily newsletter.
`
